These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 32246020)

  • 1. In vivo biodistribution analysis of transmission competent and defective RNA virus-based episomal vector.
    Komatsu Y; Tanaka C; Komorizono R; Tomonaga K
    Sci Rep; 2020 Apr; 10(1):5890. PubMed ID: 32246020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of high-titer transmission-defective RNA virus-based episomal vector using tangential flow filtration.
    Komatsu Y; Kakuya Y; Tomonaga K
    Microbiol Immunol; 2020 Sep; 64(9):602-609. PubMed ID: 32644225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of Borna disease virus-based episomal vector under physical and chemical stimulation.
    Yanai M; Sakai M; Komorizono R; Makino A; Tomonaga K
    Microbiol Immunol; 2022 Jan; 66(1):24-30. PubMed ID: 34617609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an RNA Virus-Based Episomal Vector Capable of Switching Transgene Expression.
    Yamamoto Y; Tomonaga K; Honda T
    Front Microbiol; 2019; 10():2485. PubMed ID: 31781052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Borna Disease Virus 2 (BoDV-2) Nucleoprotein Is a Conspecific Protein That Enhances BoDV-1 RNA-Dependent RNA Polymerase Activity.
    Kanda T; Horie M; Komatsu Y; Tomonaga K
    J Virol; 2021 Oct; 95(21):e0093621. PubMed ID: 34406860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA Virus-Based Episomal Vector with a Fail-Safe Switch Facilitating Efficient Genetic Modification and Differentiation of iPSCs.
    Komatsu Y; Takeuchi D; Tokunaga T; Sakurai H; Makino A; Honda T; Ikeda Y; Tomonaga K
    Mol Ther Methods Clin Dev; 2019 Sep; 14():47-55. PubMed ID: 31309127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Expression of the Envelope Glycoprotein of Orthobornaviruses Determines the Production of Mature Virus Particles.
    Sakai M; Fujita Y; Komorizono R; Kanda T; Komatsu Y; Noda T; Tomonaga K; Makino A
    J Virol; 2021 Mar; 95(5):. PubMed ID: 33268525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
    Janelidze S; Nordström U; Kügler S; Brundin P
    J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo.
    Perez MC; Hunt SP; Coffin RS; Palmer JA
    Gene Ther; 2004 Jul; 11(13):1023-32. PubMed ID: 15164091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
    Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
    Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
    Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
    J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin.
    Ye GJ; Budzynski E; Sonnentag P; Miller PE; Sharma AK; Ver Hoeve JN; Howard K; Knop DR; Neuringer M; McGill T; Stoddard J; Chulay JD
    Hum Gene Ther Clin Dev; 2015 Sep; 26(3):165-76. PubMed ID: 26390090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical Potency and Biodistribution Studies of an AAV 5 Vector Expressing Human Interferon-β (ART-I02) for Local Treatment of Patients with Rheumatoid Arthritis.
    Aalbers CJ; Bevaart L; Loiler S; de Cortie K; Wright JF; Mingozzi F; Tak PP; Vervoordeldonk MJ
    PLoS One; 2015; 10(6):e0130612. PubMed ID: 26107769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a replication-competent hepatitis B virus vector carrying secreted luciferase transgene and establishment of new hepatitis B virus replication and expression cell lines.
    Ruan J; Ping CY; Sun S; Cheng X; Han PY; Zhang YG; Sun DX
    World J Gastroenterol; 2019 Oct; 25(39):5961-5972. PubMed ID: 31660033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral vector-mediated gene expression in the nervous system of immunocompetent Wistar and T cell-deficient nude rats: preferential survival of transduced astroglial cells in nude rats.
    Hermens WT; Verhaagen J
    Hum Gene Ther; 1997 Jun; 8(9):1049-63. PubMed ID: 9189763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analyses of transgene delivery and expression in tumors inoculated with a replication-conditional or -defective viral vector.
    Ichikawa T; Chiocca EA
    Cancer Res; 2001 Jul; 61(14):5336-9. PubMed ID: 11454670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular administration of AAV overcomes pre-existing neutralizing antibodies in rhesus macaques.
    Greig JA; Calcedo R; Grant RL; Peng H; Medina-Jaszek CA; Ahonkhai O; Qin Q; Roy S; Tretiakova AP; Wilson JM
    Vaccine; 2016 Dec; 34(50):6323-6329. PubMed ID: 27817961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
    Hammond SL; Leek AN; Richman EH; Tjalkens RB
    PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrafiltered recombinant AAV8 vector can be safely administered in vivo and efficiently transduces liver.
    Kleven MD; Gomes MM; Wortham AM; Enns CA; Kahl CA
    PLoS One; 2018; 13(4):e0194728. PubMed ID: 29621273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
    Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
    Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.